Original Research
Page 27
Posts about this type
Original Research
Effectiveness of 3 Suicide Prevention Programs
February 26, 2019
Most evidence concerning suicide prevention strategies comes from either non-experimental epidemiologic designs or randomized controlled trials, but there is a growing call for data from actual clinical practice. Learn...
Original Research
CAN-BIND-1 Outcomes and Early Response Prediction in MDD
February 5, 2019
Antidepressant medications are often prescribed with little certainty about their potential effectiveness in individual patients. Can early symptom reduction help predict later symptomatic and functional outcomes of antidepressant treatment?...
Original Research
Psychotic Features in Patients With MDD
January 15, 2019
Psychotic features within major depressive disorder (MDD) are associated with poor treatment outcome. This article explores whether sociodemographic and clinical characteristics of and pharmacologic treatments received by patients with...
Original Research
Long-Term Remission With Cariprazine in Patients With Schizophrenia
January 8, 2019
When treating patients with schizophrenia, achieving stable, long-term remission is an important step toward the goal of functional recovery. This study evaluated the effect of cariprazine on several measures...
Original Research
Cost-Effectiveness of "Next-Step" Depression Treatment Strategies
December 18, 2018
Aripiprazole is commonly prescribed as a next-step pharmacotherapy for treatment-resistant depression, but its cost-effectiveness as an adjunct to antidepressants is unknown. Read this article to learn how the cost-effectiveness...
Original Research
Valbenazine for Tardive Dyskinesia: Results From the KINECT 3 Study
December 18, 2018
Could valbenazine help your patients who experience antipsychotic-induced abnormal movements? This follow-up analysis of a phase 3 study provides further insights into the efficacy of valbenazine for tardive dyskinesia...
Original Research
Caregiver Burden in PANS
December 11, 2018
Pediatric acute-onset neuropsychiatric disorder (PANS) is characterized by abrupt onset of obsessive-compulsive disorder and/or food restriction with 2 or more similarly debilitating neuropsychiatric symptoms. Read this article to learn...